Canurta is revolutionizing healthcare by developing innovative botanical therapeutics using rare cannflavins for complex diseases. With multi-potency and polypharmacology, Canurta’s treatments offer superior anti-inflammatory benefits and lower toxicity compared to traditional options. The company’s groundbreaking EkaPolyPhaia™ platform combines extraction, biosynthesis, AI, and blockchain technology to ensure supply chain traceability and robust IP. Canurta is an ideal investment opportunity for biotech investors seeking significant returns and transformative impact on global health.

Canurta Inc logo



Event details

Date: November 6 - 8, 2023

Event contact

Patrick Barry
Area Director
Europe: Automotive and Life Sciences


21 in total